financetom
Business
financetom
/
Business
/
Intuitive Surgical Expands Direct Reach: Plans Acquiring Key European da Vinci And Ion Distribution Businesses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intuitive Surgical Expands Direct Reach: Plans Acquiring Key European da Vinci And Ion Distribution Businesses
Jan 22, 2025 8:13 AM

On Tuesday, Intuitive Surgical, Inc ( ISRG ). announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories.

The acquisition, subject to regulatory approvals, will expand Intuitive’s direct presence in these regions, with the transaction expected to close in 2026.

Intuitive has entered into an agreement with its current distributors, ab medica, Abex, and Excelencia Robotica, to purchase their Intuitive product-related business.

Once the deal is finalized, the acquired businesses will be fully integrated into Intuitive’s European operations, led by Senior Vice President and General Manager Dirk Barten.

Also Read: Netflix Rises 15% In Wednesday Premarket As Streaming Giant Hikes Prices Following Record Subscriber Growth

CEO Gary Guthart expressed excitement about the opportunity to bring minimally invasive care to more patients across Europe. He highlighted the importance of having a direct presence in these countries to better understand the unique needs of customers.

“Having a direct presence in Italy, Spain, Portugal, Malta, and San Marino, and associated territories allows us to deepen our understanding of unique customer needs in these countries,” Guthart added.

Francesca Cerruti, CEO of ab medica, emphasized their long history of introducing robotic-assisted surgery in Southern Europe.

According to Benzinga Pro, ISRG stock has gained over 62% in the past year. Investors can gain exposure to the stock via Spinnaker ETF Series Langar Global HealthTech ETF .

Price Action: ISRG shares are trading higher by 1.03% to $610.33 at last check Wednesday.

Read Next:

Warren Buffett’s Pilot Co Exits Global Oil Trading, Refocuses On US Operations: Report

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved